News Announcement

Kwality Pharmaceuticals: Board Meeting Outcome for Submission Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended On 30.06.2022 Under Regulation 33 Of The SEBI (LODR) Regulations 2015

With respect to captioned subject we wish to inform you that the Board of Directors in its Meeting held today has inter-alia considered and approved the standalone and consolidated Un-Audited Financial Results for the quarter ended June 30 2022. We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 for the quarter ended on 30.06.2022 along with the limited review reports thereon.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.